The Chainsmokers See A Lot Of Success in 2018

2018 has been the biggest year for The Chainsmokers ever and it seems to just be getting bigger. When Forbes recently released their list of the highest-paid DJ’s in the world, the duo made it to the number 2 spot. Some of the other artists on the list included David Guetta, Diplo, and Steve Aoki. The Chainsmokers is made up of Alex Pall and Drew Taggart. The duo is based out of New York and in 2018 they have earned upwards of $45.5 million.

They are known for their singles like “Sick Boy” and “Closer” and they have a residency with Wynn Nightlife that pays somewhere in the 6 figures per night that they perform. Alex Pall, co-founder of The Chainsmokers has stated that he wants to know what happens next with their lives and career. Their premiere album Memories… Do Not Open has been at the tops of the Billboard charts and has been certified platinum.

Their single “Closer” off of the album Memories… Do Not Open has hit diamond status and has shipped more than 10 million units. This big news was announced through their social media on Instagram. Bot Drew Pall and Alex Pall posted it on their pages along with Halsey and The Chainsmokers pages. The singer Halsey was featured on the single and many say helped launch her into stardom. While she had already been receiving a fair amount of attention before the single was released, “Closer” was her breakout hit. She proved to the world that she was on the rise.

Since its release in 2016, and has earned a lot of recognition and awards. While it was nominated for a Grammy, the award for Best Pop Duo/Group Performance went to “Stressed Out” by 21 Pilots. Even though the song is now 2 years old, it’s still is making good sales and is frequently on the radio. On Billboard’s Dance/Electronic chart, it set a record for being the longest-running song at No. 1. This record was recently beat by “The Middle”, but it was still an impressive accomplishment for The Chainsmokers.

https://www.hollywoodreporter.com/news/chainsmokers-produce-movie-based-song-paris-1158203

Marc Beer Is Utilizing His Healthcare Vision To Help Fill A Game Changing Need In Women’s Health:

Marc Beer is a figure who is well known in health care circles due to his involvement in numerous projects in the areas of biotech, pharmaceutical development and diagnostic devices over the past twenty plus years. He sports an impressive resume that includes time as the Chairman and Founder in MInerva Neurosciences Inc’s Compensation Committee as well as spending time as the Founder and Chairman with Good Start Genetics. Marc Beer had a huge year in 2000 when he took over the CEO role of ViaCell, an organization that did critical research in the area of umbilical cord stem cells. Marc’s tenure saw this firm grow into a company that had over three hundred employees.

 

These days, Marc Beer is placing his focus on his latest and perhaps most exciting healthcare industry endeavour with Renovia Inc. This innovative outfit is doing critical work in the area of research and treatment of pelvic floor disorders in women. Marc Beer and his team have been doing some impressive work that has already see its first product approved by the FDA and he has done some creative work in coming up with valuable capital to fund the operation.

 

Marc Beer was recently proud to announce the fact that he has secured some great funding for Renovia during the course of a new round. This critical capital amounts to more than $30 million and was acquired during a Series B round. There was also an additional $10 million that Marc Beer was able to gain in terms of venture debt. This critical funding allows Marc Beer the ability to truly put to use his extensive experience and his deep knowledge in helping to make sure that Renovia Inc. is able to continue to do the critical work in the realm of research and treatment for disorders that in are regard to the pelvic floor.

 

The very first product release from Renovia Inc., a drug known as Leva, has now been approved for use by the Food and Drug Administration. The fact of the matter is that the development of this revolutionary new drug has been made possible due to Marc Beer’s ability to garner all of this necessary capital. The Longwood Fund was a major contributor along with Ascension Ventures. The Perceptive Advisers were the other major contributor to the work that Renovia and Marc Beer are doing. There are now four new products that Renovia will be testing and the funding from this great investors will help to make this testing a reality.

 

It is Marc Beer’s overall ability to see a need that needs to be filled in healthcare and then use his vision to fill that need that really caused him to start Renovia Inc. This was the case in his recognition of the need for a better understanding and better treatment options in regard to women’s pelvic floor disorders. Learn more: https://renoviainc.com/leadership/